Zevenbergen Capital Investments LLC Regeneron Pharmaceuticals, Inc. Transaction History

Zevenbergen Capital Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $26.1 Million - $30.3 Million	-74,197 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $14.2 Million - $17.2 Million	-49,850 Reduced 40.19%	74,197 $25.6 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.77 Million - $2.21 Million	-5,618 Reduced 4.33%	124,047 $42.7 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $4.67 Million - $6.12 Million	-13,020 Reduced 9.12%	129,665 $48.7 Million
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $61.6 Million - $71.9 Million	142,685	142,685 $63.8 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.